GERMANTOWN, Md., Nov. 6, 2025 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the Company will release third quarter 2025 financial results and...
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13
Seeking Alpha / 15 hours ago 2 Views
Comments